Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Experimental evidence and network pharmacology-based analysis reveal the molecular mechanism of Tongxinluo capsule administered in coronary heart diseases

29 Sept 2020

Abstract excerpt

BACKGROUND: Tongxinluo (TXL) capsule, a polypharmacy derived from traditional Chinese medicine (TCM), has been widely used in coronary heart disease (CHD), while the underlying mechanism of TXL capsule is still unclear. The present study aimed at investigating the underlying mechanism of TXL acting on CHD patients and providing substantial evidence in molecular evidence by means of a network pharmacological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis and Cardiovascular Diseases
Share to Cardiovascular Function and Risk Factors
Share to Lipid metabolism and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32990315
DOI: 10.1042/bsr20201349

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Experimental evidence and network pharmacology-based analysis reveal the molecular mechanism of Tongxinluo capsule administered in coronary heart diseasesPMID 32990315Read ↗

A Multi-Scale Bioinformatics Study on Novel Mechanism of Xintong Granule for Treating Coronary Heart Disease by Network Pharmacology and Molecular Docking VerificationSemantic proximity Read ↗

Network pharmacology and molecular docking in the exploration of Taohong Siwu decoction against coronary heart diseaseSemantic proximity Read ↗

Research on the Mechanism of Wuwei Yuganzi San in the Treatment of Coronary Heart Disease Based on Network PharmacologySemantic proximity Read ↗

Network pharmacology, molecular docking, and experimental study for the mechanisms of Qishen Yiqi Pills against Cardiovascular DiseasesSemantic proximity Read ↗

Study on biological impacts of Xuefu Zhuyu Decoction in the treatment of coronary heart disease through Investigating target genes and molecular dockingSemantic proximity Read ↗

Molecular Mechanism of Danxiong Tongmai Granules in Treatment of Coronary Heart DiseaseSemantic proximity Read ↗

Network Pharmacology and Molecular Docking Analysis of Shanhaidan granules in treatment of coronary heart disease angina pectorisSemantic proximity Read ↗

A Network Pharmacology Analysis to Reveal the Molecular Mechanism of Zhizi-Danshen on Coronary Heart DiseaseSemantic proximity Read ↗

Exploring the Pharmacological Mechanism of the modified Chinese medicine formulas “Shenfu-Linguizhugan decoction” treating Dilated cardiomyopathy Based on Network PharmacologySemantic proximity Read ↗

A Network Pharmacology-Based Study on Active Ingredients of Corydalis Rhizoma on Coronary Heart DiseaseSemantic proximity Read ↗

A Network Pharmacology-Based Study on Active Ingredients of Corydalis Rhizoma on Coronary Heart DiseaseSemantic proximity Read ↗

A Network Pharmacology Study to Explore the Underlying Mechanism of Safflower (Carthamus Tinctorius L.) in the Treatment of Coronary Heart DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.